Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Aug 19, 2015 4:33 PM EDT
INVESTING
Why to Buy These 5 Under-$10 Stocks ASAP
By Roberto Pedone
Aug 20, 2014 6:00 AM EDT
MARKETS
Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline
By Jane Searle
Mar 24, 2014 4:14 PM EDT
STOCKS
22 Biotech Stock Predictions for 2014
By Adam Feuerstein
Jan 6, 2014 7:58 AM EST
INVESTING
5 Stocks Under $10 Set to Soar
By Roberto Pedone
Sep 26, 2013 2:33 PM EDT
INVESTING
7 Under-$10 Stocks Racing Higher
By Roberto Pedone
Sep 11, 2013 8:30 AM EDT
INVESTING
3 Biotech Stocks Under $10 to Trade for Breakouts
By Roberto Pedone
Jul 31, 2013 8:03 AM EDT
STOCKS
Top Insider Trades: AEGR VVTV CCO ALXA
By Jonathan Moreland
Jan 23, 2013 8:59 AM EST
INVESTING
5 Stocks With Big Insider Buying
By Roberto Pedone
Jan 2, 2013 11:33 AM EST
STOCKS
13 Biotech Stock Predictions for 2013
By Adam Feuerstein
Jan 2, 2013 6:00 AM EST
STOCKS
Stocks to Watch: Regions, Google, RIM
By Joseph Woelfel
Dec 24, 2012 5:48 AM EST
STOCKS
Shorting Alexza Pharma On FDA's Adasuve Approval
By Mark Messier
Dec 19, 2012 7:00 AM EST
MARKETS
Stocks Socked Despite Upbeat China Numbers; Apple Falls
By Andrea Tse
Dec 14, 2012 4:29 PM EST
VIDEO
The Next Big Thing in Biotech: FDA Decisions
By Adam Feuerstein
Dec 14, 2012 5:30 AM EST
STOCKS
Alexza Pharma: Premium Selling Options Strategy
By Tony Pelz
Dec 12, 2012 11:27 AM EST
STOCKS
Alexza Pharma: Run-Up Trade Into December's Approval Decisions
By Mark Messier
Nov 20, 2012 8:03 AM EST
STOCKS
21 Most Volatile Biopharma Stocks Closing Out 2012
By Adam Feuerstein
Nov 5, 2012 6:00 AM EST
INVESTING
5 Stocks Poised for Breakouts
By Roberto Pedone
Oct 5, 2012 1:13 PM EDT
INVESTING
3 Health Care Stocks Under $10 Making Big Moves
By Roberto Pedone
Oct 2, 2012 2:35 PM EDT
MARKETS
8 Stocks Under $10 Surging Higher
By Roberto Pedone
Aug 28, 2012 2:19 PM EDT
STOCKS
31 Drugs Facing FDA Approval in 2012-2013
By Adam Feuerstein
Aug 20, 2012 8:00 AM EDT
INVESTING
5 Stocks Under $10 Set to Soar
By Roberto Pedone
Aug 16, 2012 1:11 PM EDT
STOCKS
Alexza Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
By Seeking Alpha
Aug 10, 2012 7:25 PM EDT
STOCKS
28 Drugs Facing FDA Approval in 2012-2013
By Adam Feuerstein
Jul 24, 2012 7:38 AM EDT
MARKETS
7 Stocks Under $10 With Relative Strength
By Roberto Pedone
Jun 25, 2012 2:36 PM EDT